GALLIUM (68GA) CHLORIDE
Sponsors
Amsterdam UMC, CHU de Brest, Radboud universitair medisch centrum / RADBOUDUMC, Universitair Medisch Centrum Utrecht, Stichting Amsterdam UMC
Conditions
Carcinoma of the parotid glandEndometrial cancerInflammatory disordersOral cancerPulmonary aspergillosisRectal cancercholangiocarcinoma (bile duct cancer)pancreatic carcinoma (pancreatic cancer)
Phase 2
iMagIng pulmonaRy Aspergillosis using Gallium-68-dEferoxamine (MIRAGE)
RecruitingCTIS2023-509744-10-00
Start: 2025-04-01Target: 10Updated: 2024-04-18
[68Ga]Ga-FAPI-46 positron emission tomography in pancreatobiliary cancers: a pharmacokinetics, repeatability and diagnostic accuracy study. (PANSCAN-1)
RecruitingCTIS2024-516486-36-00
Start: 2025-03-24Target: 63Updated: 2024-09-26
68Gallium-FAPI PET/CT imaging in Chronic inflammatory and fibrotic diseases (PARADISE study)
RecruitingCTIS2023-508190-84-01
Start: 2025-03-13Target: 390Updated: 2025-06-17
Phase 3
Sentinel lymph node biopsy in patients with parotid gland carcinoma using a combination of 99mTc-nanocolloid and 68Ga-tilmanocept PET/CT: A feasibility study. (SNparotis)
Not yet recruitingCTIS2024-514233-37-00
Target: 10Updated: 2024-07-12
SENtinel lymph node mapping with GAllium-68-tilmanocept PET/CT in high/high- intermediate risk endometrial cancer: a proof-of-concept study
Not yet recruitingCTIS2024-516708-40-00
Target: 10Updated: 2024-11-15
Sentinel lymph node (SLN) detection in early oral cancer using Gallium-68-Tilmanocept PET/CT.
SuspendedCTIS2025-521682-27-00
Target: 94Updated: 2025-04-18
Phase 4
FAPi-PET imaging of in vivo early fistula healing in perianal Crohn’s disease: PERSIST study
RecruitingCTIS2023-505317-25-00
Start: 2023-11-24Target: 10Updated: 2024-06-24
[68Ga]Ga-FAPI-46 positron emission tomography for detection of lymph node metastasis in early rectal cancer (FARE Trial)
RecruitingCTIS2023-506594-35-00
Start: 2025-03-24Target: 50Updated: 2025-12-10